{"id":50707,"date":"2022-11-23T09:37:46","date_gmt":"2022-11-23T14:37:46","guid":{"rendered":"https:\/\/wfh.org\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/"},"modified":"2024-04-10T09:37:47","modified_gmt":"2024-04-10T13:37:47","slug":"le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda","status":"publish","type":"post","link":"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/","title":{"rendered":"Le premier m\u00e9dicament de th\u00e9rapie g\u00e9nique pour l\u2019h\u00e9mophilie B approuv\u00e9 par la FDA"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"50707\" class=\"elementor elementor-50707 elementor-50572\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-abb97a8 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"abb97a8\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-df2695c\" data-id=\"df2695c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7284660 elementor-widget elementor-widget-text-editor\" data-id=\"7284660\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>L\u2019<a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapy-treat-adults-hemophilia-b\" target=\"_blank\" rel=\"noopener\">\u00e9tranacogene dezaparvovec-drlb<\/a> permet aux adultes \u00e9ligibles et trait\u00e9\u00b7es par th\u00e9rapie g\u00e9nique de produire leur propre facteur IX, ce qui permet de faire baisser les risques de saignements ainsi que de r\u00e9duire voire \u00e9liminer les besoins de traitement prophylactique. Dans le cadre de l\u2019\u00e9tude clinique qui est toujours en cours, le traitement a r\u00e9duit le taux de saignements annuels, et 94\u00a0% des patient\u00b7es (soit 51 sur 54) ont cess\u00e9 leur traitement prophylactique \u00e0 base de facteur IX et ne l\u2019ont pas repris \u00e0 ce jour. Les effets secondaires les plus fr\u00e9quents (concernant 5\u00a0% de l\u2019\u00e9chantillon ou plus) sont une augmentation des enzymes h\u00e9patiques, des maux de t\u00eate, des niveaux \u00e9lev\u00e9s d\u2019une enzyme du sang, un \u00e9tat grippal, des r\u00e9actions li\u00e9es \u00e0 l\u2019injection, une fatigue, des naus\u00e9es ainsi qu\u2019une faiblesse g\u00e9n\u00e9rale.<\/p>\n<p>Pour lire le communiqu\u00e9 de presse de la FDA, <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapy-treat-adults-hemophilia-b\" target=\"_blank\" rel=\"noopener\">cliquez ici<\/a>.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>La Food and Drug Administration (FDA) des \u00c9tats-Unis vient d\u2019approuver l\u2019\u00e9tranacogene dezaparvovec-drlb (HEMGENIX), la premi\u00e8re th\u00e9rapie g\u00e9nique ponctuelle pour les adultes concern\u00e9\u00b7es atteint\u00b7es d\u2019h\u00e9mophilie B. Cette th\u00e9rapie est approuv\u00e9e pour le traitement des adultes atteint\u00b7es d\u2019h\u00e9mophilie B \u00e9tant actuellement sous traitement prophylactique \u00e0 base de facteur IX, en situation d\u2019h\u00e9morragie mortelle ou ayant des ant\u00e9c\u00e9dents d\u2019une telle h\u00e9morragie, ou bien souffrant d\u2019\u00e9pisodes r\u00e9p\u00e9t\u00e9s et graves de saignements spontan\u00e9s.<\/p>\n","protected":false},"author":13,"featured_media":30514,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[177,173],"tags":[],"search-category":[85],"class_list":["post-50707","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualite-medicale","category-dernieres-nouvelles","search-category-article"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Le premier m\u00e9dicament de th\u00e9rapie g\u00e9nique pour l\u2019h\u00e9mophilie B approuv\u00e9 par la FDA | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le premier m\u00e9dicament de th\u00e9rapie g\u00e9nique pour l\u2019h\u00e9mophilie B approuv\u00e9 par la FDA\" \/>\n<meta property=\"og:description\" content=\"La Food and Drug Administration (FDA) des \u00c9tats-Unis vient d\u2019approuver l\u2019\u00e9tranacogene dezaparvovec-drlb (HEMGENIX), la premi\u00e8re th\u00e9rapie g\u00e9nique ponctuelle pour les adultes concern\u00e9\u00b7es atteint\u00b7es d\u2019h\u00e9mophilie B. Cette th\u00e9rapie est approuv\u00e9e pour le traitement des adultes atteint\u00b7es d\u2019h\u00e9mophilie B \u00e9tant actuellement sous traitement prophylactique \u00e0 base de facteur IX, en situation d\u2019h\u00e9morragie mortelle ou ayant des ant\u00e9c\u00e9dents d\u2019une telle h\u00e9morragie, ou bien souffrant d\u2019\u00e9pisodes r\u00e9p\u00e9t\u00e9s et graves de saignements spontan\u00e9s.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/wfhemophilia\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-23T14:37:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-10T13:37:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2501\" \/>\n\t<meta property=\"og:image:height\" content=\"1459\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mitch Semienchuk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mitch Semienchuk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/\"},\"author\":{\"name\":\"Mitch Semienchuk\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b\"},\"headline\":\"Le premier m\u00e9dicament de th\u00e9rapie g\u00e9nique pour l\u2019h\u00e9mophilie B approuv\u00e9 par la FDA\",\"datePublished\":\"2022-11-23T14:37:46+00:00\",\"dateModified\":\"2024-04-10T13:37:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/\"},\"wordCount\":173,\"publisher\":{\"@id\":\"https:\/\/wfh.org\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png\",\"articleSection\":[\"Actualit\u00e9 m\u00e9dicale\",\"Derni\u00e8res nouvelles\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/\",\"url\":\"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/\",\"name\":\"Le premier m\u00e9dicament de th\u00e9rapie g\u00e9nique pour l\u2019h\u00e9mophilie B approuv\u00e9 par la FDA | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png\",\"datePublished\":\"2022-11-23T14:37:46+00:00\",\"dateModified\":\"2024-04-10T13:37:47+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/#primaryimage\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png\",\"width\":2501,\"height\":1459,\"caption\":\"lgoo\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wfh.org\/fr\/#website\",\"url\":\"https:\/\/wfh.org\/fr\/\",\"name\":\"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\",\"description\":\"WFH - World Federation of Hemophilia\",\"publisher\":{\"@id\":\"https:\/\/wfh.org\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wfh.org\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/wfh.org\/fr\/#organization\",\"name\":\"World Federation of Hemophilia\",\"url\":\"https:\/\/wfh.org\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"width\":210,\"height\":63,\"caption\":\"World Federation of Hemophilia\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/wfhemophilia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b\",\"name\":\"Mitch Semienchuk\",\"sameAs\":[\"analytics\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Le premier m\u00e9dicament de th\u00e9rapie g\u00e9nique pour l\u2019h\u00e9mophilie B approuv\u00e9 par la FDA | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/","og_locale":"fr_FR","og_type":"article","og_title":"Le premier m\u00e9dicament de th\u00e9rapie g\u00e9nique pour l\u2019h\u00e9mophilie B approuv\u00e9 par la FDA","og_description":"La Food and Drug Administration (FDA) des \u00c9tats-Unis vient d\u2019approuver l\u2019\u00e9tranacogene dezaparvovec-drlb (HEMGENIX), la premi\u00e8re th\u00e9rapie g\u00e9nique ponctuelle pour les adultes concern\u00e9\u00b7es atteint\u00b7es d\u2019h\u00e9mophilie B. Cette th\u00e9rapie est approuv\u00e9e pour le traitement des adultes atteint\u00b7es d\u2019h\u00e9mophilie B \u00e9tant actuellement sous traitement prophylactique \u00e0 base de facteur IX, en situation d\u2019h\u00e9morragie mortelle ou ayant des ant\u00e9c\u00e9dents d\u2019une telle h\u00e9morragie, ou bien souffrant d\u2019\u00e9pisodes r\u00e9p\u00e9t\u00e9s et graves de saignements spontan\u00e9s.","og_url":"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/","og_site_name":"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","article_publisher":"https:\/\/www.facebook.com\/wfhemophilia\/","article_published_time":"2022-11-23T14:37:46+00:00","article_modified_time":"2024-04-10T13:37:47+00:00","og_image":[{"width":2501,"height":1459,"url":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png","type":"image\/png"}],"author":"Mitch Semienchuk","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Mitch Semienchuk","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/#article","isPartOf":{"@id":"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/"},"author":{"name":"Mitch Semienchuk","@id":"https:\/\/wfh.org\/fr\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b"},"headline":"Le premier m\u00e9dicament de th\u00e9rapie g\u00e9nique pour l\u2019h\u00e9mophilie B approuv\u00e9 par la FDA","datePublished":"2022-11-23T14:37:46+00:00","dateModified":"2024-04-10T13:37:47+00:00","mainEntityOfPage":{"@id":"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/"},"wordCount":173,"publisher":{"@id":"https:\/\/wfh.org\/fr\/#organization"},"image":{"@id":"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png","articleSection":["Actualit\u00e9 m\u00e9dicale","Derni\u00e8res nouvelles"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/","url":"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/","name":"Le premier m\u00e9dicament de th\u00e9rapie g\u00e9nique pour l\u2019h\u00e9mophilie B approuv\u00e9 par la FDA | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","isPartOf":{"@id":"https:\/\/wfh.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/#primaryimage"},"image":{"@id":"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png","datePublished":"2022-11-23T14:37:46+00:00","dateModified":"2024-04-10T13:37:47+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/wfh.org\/fr\/article\/le-premier-medicament-de-therapie-genique-pour-lhemophilie-b-approuve-par-la-fda\/#primaryimage","url":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png","width":2501,"height":1459,"caption":"lgoo"},{"@type":"WebSite","@id":"https:\/\/wfh.org\/fr\/#website","url":"https:\/\/wfh.org\/fr\/","name":"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","description":"WFH - World Federation of Hemophilia","publisher":{"@id":"https:\/\/wfh.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wfh.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/wfh.org\/fr\/#organization","name":"World Federation of Hemophilia","url":"https:\/\/wfh.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","width":210,"height":63,"caption":"World Federation of Hemophilia"},"image":{"@id":"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/wfhemophilia\/"]},{"@type":"Person","@id":"https:\/\/wfh.org\/fr\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b","name":"Mitch Semienchuk","sameAs":["analytics"]}]}},"_links":{"self":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/50707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/comments?post=50707"}],"version-history":[{"count":0,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/50707\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/media\/30514"}],"wp:attachment":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/media?parent=50707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/categories?post=50707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/tags?post=50707"},{"taxonomy":"search-category","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/search-category?post=50707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}